Leo Price leads Crown Bioscience’s in vitro services in Europe and the US and the Crown Bioscience sites in The Netherlands, Leiden and Utrecht. He joined Crown Bioscience in 2021 from OcellO, following Crown Bioscience’s acquisition of the company. Dr Price was the founder of OcellO, a leading provider of high content screening services, using organoids and other advanced 3D cell culture models, and served as their CEO and CSO for ten years.

Prior to founding OcellO, Leo was a Faculty Member and Group Leader at Leiden University for five years and completed three postdoctoral studies with UMC Utrecht, The Netherlands Cancer Institute and Scripps Research Institute. He received his PhD in Cell Physiology from University College London and is currently a guest Associate Professor at the Leiden Academic Centre for Drug Research, Leiden University.